XOMA Royalty (XOMA) Operating Margin Growth (5y) (2016 - 2026)
XOMA Royalty (XOMA) Operating Margin Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
170,997.00 |
| Dec 31, 2025 |
-9,243.00 |
| Sep 30, 2025 |
-10,835.00 |
| Jun 30, 2025 |
80,129.00 |
| Mar 31, 2025 |
127,142.00 |
| Dec 31, 2024 |
-50,250.00 |
| Sep 30, 2024 |
-6.26 Mn |
| Jun 30, 2024 |
28,913.00 |
| Mar 31, 2024 |
-54,751.00 |
| Dec 31, 2023 |
-88,442.00 |
| Sep 30, 2023 |
-10,493.00 |
| Jun 30, 2023 |
-73,320.00 |
| Dec 31, 2022 |
-38,038.00 |
| Sep 30, 2022 |
-104,858.00 |
| Jun 30, 2022 |
-49,698.00 |
| Mar 31, 2022 |
413,354.00 |
| Dec 31, 2021 |
1.85 Mn |
| Sep 30, 2021 |
154,840.00 |
| Jun 30, 2021 |
372,720.00 |
| Mar 31, 2021 |
-136,079.00 |
